Psoriasis Treatment Market:Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jun 2022| TMR1835B| Transparency

Report Highlights

Psoriasis Treatment Market – Scope of Report

TMR’s report on the global psoriasis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global psoriasis treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global psoriasis treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the psoriasis treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global psoriasis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global psoriasis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global psoriasis treatment market.

The report delves into the competitive landscape of the global psoriasis treatment market. Key players operating in the global psoriasis treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global psoriasis treatment market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market psoriasis treatment.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Frequently Asked Questions (FAQs)

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 2 : Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2031
  • Table 3 : Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 4 : Global Psoriasis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 5 : North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 6 : North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
  • Table 7 : North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 8 : North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 9 : Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 10 : Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
  • Table 11 : Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 12 : Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 13 : Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 14 : Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
  • Table 15 : Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 16 : Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 17 : Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 18 : Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
  • Table 19 : Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 20 : Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 21 : Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 22 : Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
  • Table 23 : Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 24 : Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Figure 1 : Global Psoriasis Treatment Market Snapshot, 2021
  • Figure 2 : Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2017–2031
  • Figure 3 : Global Psoriasis Treatment Market Value Share, by Route of Administration, 2021
  • Figure 4 : Global Psoriasis Treatment Market Value Share, by Region, 2021
  • Figure 5 : Global Psoriasis Treatment Market Value Share, by Drug Class, 2021
  • Figure 6 : Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2021
  • Figure 7 : Regulatory Approval Process - U.S.
  • Figure 8 : Regulatory Approval Process - Europe
  • Figure 9 : Regulatory Approval Process - Japan
  • Figure 10 : Global Psoriasis Treatment Market Value Share, by Drug Class, 2021 and 2031
  • Figure 11 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TNF Inhibitors, 2017–2031
  • Figure 12 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Interleukin Inhibitors, 2017–2031
  • Figure 13 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin D Analogs, 2017–2031
  • Figure 14 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017–2031
  • Figure 15 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
  • Figure 16 : Global Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 17 : Global Psoriasis Treatment Market Value Share, by Route of Administration, 2021 and 2031
  • Figure 18 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2031
  • Figure 19 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2017–2031
  • Figure 20 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2017–2031
  • Figure 21 : Global Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 22 : Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 23 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2031
  • Figure 24 : Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2031
  • Figure 25 : Global Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 26 : Global Psoriasis Treatment Market Value Share, by Region, 2021 and 2031
  • Figure 27 : Global Psoriasis Treatment Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 28 : North America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 29 : North America Psoriasis Treatment Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 30 : North America Psoriasis Treatment Market Value Share, by Drug Class, 2021 and 2031
  • Figure 31 : North America Psoriasis Treatment Market Value Share, by Route of Administration, 2021 and 2031
  • Figure 32 : North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 33 : North America Psoriasis Treatment Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 34 : North America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 35 : North America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 36 : North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 37 : Europe Psoriasis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
  • Figure 38 : Europe Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 39 : Europe Psoriasis Treatment Market Value Share, by Drug Class, 2021 and 2031
  • Figure 40 : Europe Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 41 : Europe Psoriasis Treatment Market Value Share, by Route of Administration, 2021 and 2031
  • Figure 42 : Europe Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 43 : Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 44 : Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 45 : Europe Psoriasis Treatment Market Value Share, by Country/Sub-region, 2021 and 2031
  • Figure 46 : Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 47 : Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 48 : Asia Pacific Psoriasis Treatment Market Value Share, by Drug Class, 2021 and 2031
  • Figure 49 : Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 50 : Asia Pacific Psoriasis Treatment Market Value Share, by Route of Administration, 2021 and 2031
  • Figure 51 : Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 52 : Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 53 : Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 54 : Asia Pacific Psoriasis Treatment Market Value Share, by Country/Sub-region, 2021 and 2031
  • Figure 55 : Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 56 : Latin America Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 57 : Latin America Psoriasis Treatment Market Value Share, by Drug Class, 2021 and 2031
  • Figure 58 : Latin America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 59 : Latin America Psoriasis Treatment Market Value Share, by Route of Administration, 2021 and 2031
  • Figure 60 : Latin America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 61 : Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 62 : Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 63 : Latin America Psoriasis Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 64 : Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 65 : Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 66 : Middle East & Africa Psoriasis Treatment Market Value Share, by Drug Class, 2021 and 2031
  • Figure 67 : Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 68 : Middle East & Africa Psoriasis Treatment Market Value Share, by Route of Administration, 2021 and 2031
  • Figure 69 : Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 70 : Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 71 : Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 72 : Middle East & Africa Market Value Share, by Country/Sub-region, 2021 and 2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Similar Reports from Transparency

Psoriasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Date - Oct 2019
  • Code - TMR1835A

Psoriasis Treatment Market - Scope of the Report

TMR’S report on the global psoriasis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global psoriasis treatment market ...

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS